EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Unveiling the arthritis divide: Exploring treatment response and impact in late-onset vs. young-onset rheumatoid arthritis

Nariaki Hao, Hajime Ishikawa, Asami Abe, Masanori Sudo, Sayuri Takamura, Hiroshi Otani, Satoshi Ito, Kiyoshi Nakazono, Akira Murasawa

Modern Rheumatology · 2024

DOI: 10.1093/mr/roae069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Rheumatology, 2024. Verfasst von Nariaki Hao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Niigata Rheumatic Center, Niigata, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Age of Onset, Antirheumatic Agents, Activities of Daily Living. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The impact of osteoarthritis (OA) on the initial treatment response of rheumatoid arthritis (RA) by treat-to-target practice was compared between the patients with an onset age of ≥65 years old [late-onset RA (LORA)] and those with an onset age of <65 years old [young-onset RA (YORA)].

Methods

A retrospective study was conducted on the patients with RA, who were referred to Department of Rheumatology, Niigata Rheumatic Center without treatment between January 2021 and July 2022. Patients with grade ≥3 OA according to the Kellgren–Lawrence (K–L) classification in either the knee or hand were classified in the OA (+) group and others were in the OA (−) group. The clinical data were compared at diagnosis and 1 year after the initial treatment between the groups for 74 LORA and 59 YORA patients, respectively.

Results

One year after starting treatment in the LORA patients, the OA (+) group had poorer disease activity control and greater disability in several activities of daily living than the OA (−) group. In the YORA patients, there were no differences in activities of daily living disability between the groups.

Conclusions

In the initial treatment of the LORA patients, the prevalence of OA was high, and the impact of OA on LORA was larger than on YORA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidAge of OnsetAntirheumatic AgentsActivities of Daily LivingHumansFemaleMaleMiddle AgedRetrospective StudiesAgedTreatment OutcomeAdultSeverity of Illness IndexOsteoarthritis

Stichwörter der Autor:innen

Osteoarthritisfunctional remissionlate-onset rheumatoid arthritisrheumatoid arthritisyoung-onset rheumatoid arthritis

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Department of Rheumatology, Niigata Rheumatic Center, Niigata, Japan.

Zitieren

APA

Hao, N., Ishikawa, H., Abe, A., Sudo, M., Takamura, S., Otani, H., Ito, S., Nakazono, K., & Murasawa, A. (2024). Unveiling the arthritis divide: Exploring treatment response and impact in late-onset vs. young-onset rheumatoid arthritis. Modern Rheumatology. https://doi.org/10.1093/mr/roae069

Vancouver

Hao N, Ishikawa H, Abe A, Sudo M, Takamura S, Otani H, et al. Unveiling the arthritis divide: Exploring treatment response and impact in late-onset vs. young-onset rheumatoid arthritis. Modern Rheumatology. 2024. doi:10.1093/mr/roae069

BibTeX
@article{Hao2024,
  author = {Hao, Nariaki and Ishikawa, Hajime and Abe, Asami and Sudo, Masanori and Takamura, Sayuri and Otani, Hiroshi and Ito, Satoshi and Nakazono, Kiyoshi and Murasawa, Akira},
  title = {Unveiling the arthritis divide: Exploring treatment response and impact in late-onset vs. young-onset rheumatoid arthritis},
  journal = {Modern Rheumatology},
  year = {2024},
  doi = {10.1093/mr/roae069}
}
Kostenlos starten →